Sodium valproate warning

Manufacturer adds new paternal exposure warnings to the Product Information and Consumer Medicine Information for Epilim  Sanofi-Aventis is adding warnings to its Epilim (sodium valproate) anticonvulsant medication following the publication of a retrospective study that suggested there may be an increased risk of neurodevelopmental disorders in children born to men who use the treatment.